review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Scott A Armstrong | |
Florian H Heidel | |||
Brenton G Mar | |||
P2860 | cites work | LDL-receptor-related proteins in Wnt signal transduction | Q24290392 |
MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors | Q24290574 | ||
GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter | Q24294866 | ||
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly | Q24312910 | ||
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling | Q24316697 | ||
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia | Q24597256 | ||
Regulation of myeloid leukaemia by the cell-fate determinant Musashi | Q24634359 | ||
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 | ||
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins | Q28116567 | ||
Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway | Q28118992 | ||
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 | ||
Hedgehog signaling in animal development: paradigms and principles | Q28208463 | ||
Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration | Q28238880 | ||
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B | Q28247684 | ||
Mutations affecting segment number and polarity in Drosophila | Q28273492 | ||
Lack of beta-catenin affects mouse development at gastrulation | Q28274575 | ||
In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog | Q28275763 | ||
Tissue repair and stem cell renewal in carcinogenesis | Q28294006 | ||
Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta | Q28505773 | ||
Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R symmetry by the mouse node | Q28594387 | ||
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML | Q29614278 | ||
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress | Q29615562 | ||
Notch signaling | Q29618190 | ||
Convergence of Wnt, beta-catenin, and cadherin pathways | Q29619504 | ||
Imaging hematopoietic precursor division in real time | Q30481466 | ||
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials | Q33767211 | ||
Hedgehog signaling is dispensable for adult hematopoietic stem cell function | Q34039421 | ||
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia | Q34157874 | ||
Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. | Q34346883 | ||
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. | Q34568144 | ||
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors | Q34641731 | ||
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. | Q34722375 | ||
Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis | Q34727652 | ||
Notch signaling in hematopoiesis and early lymphocyte development | Q34941720 | ||
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. | Q34978382 | ||
Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo | Q36488720 | ||
Gli1 is a target of Sonic hedgehog that induces ventral neural tube development | Q36870138 | ||
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organiz | Q36895799 | ||
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation | Q37106907 | ||
FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system | Q37121014 | ||
Hematopoietic stem cell development is dependent on blood flow. | Q37294702 | ||
Hedgehog beyond medulloblastoma and basal cell carcinoma | Q37677865 | ||
Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia | Q37827278 | ||
An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity | Q38342595 | ||
β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells | Q39620290 | ||
TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia | Q39744014 | ||
Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. | Q39782714 | ||
DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency | Q39815141 | ||
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia | Q40001372 | ||
The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo | Q40124647 | ||
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. | Q40219637 | ||
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. | Q40252270 | ||
Trans-repression of beta-catenin activity by nuclear receptors | Q40634804 | ||
Translational repression determines a neuronal potential in Drosophila asymmetric cell division | Q40808595 | ||
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. | Q42723875 | ||
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials | Q42849516 | ||
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial | Q42851077 | ||
Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells | Q44239025 | ||
Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. | Q46129185 | ||
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. | Q46248213 | ||
beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia | Q46345796 | ||
Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation | Q46388996 | ||
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity | Q47634506 | ||
Foxo3a is essential for maintenance of the hematopoietic stem cell pool. | Q51960990 | ||
Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia. | Q52587062 | ||
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. | Q53362332 | ||
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. | Q54581100 | ||
Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling | Q73167897 | ||
Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis | Q81250982 | ||
Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance | Q81308407 | ||
Acute myeloid leukemia and the Wnt pathway | Q84423759 | ||
P433 | issue | 2 | |
P921 | main subject | leukemia | Q29496 |
myeloid leukemia | Q11688946 | ||
P304 | page(s) | 109-117 | |
P577 | publication date | 2011-07-29 | |
P1433 | published in | International Journal of Hematology | Q6051416 |
P1476 | title | Self-renewal related signaling in myeloid leukemia stem cells | |
P478 | volume | 94 |
Q38848436 | ADCY7 supports development of acute myeloid leukemia. |
Q34047994 | Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia |
Q35677279 | Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells |
Q37026763 | Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment |
Q38749763 | Effect of Over-Expression of Zinc-Finger Protein (ZFX) on Self-Renewal and Drug-Resistance of Hepatocellular Carcinoma. |
Q38051191 | Epigenetic regulation of hematopoiesis |
Q92284294 | Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells |
Q37734751 | IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics |
Q92623047 | Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia |
Q36699009 | Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies |
Q39019365 | Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma |
Q48939103 | Pituitary Regeneration: It'll Knock Your SOX Off! |
Q47747424 | SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis |
Q38106623 | Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasms |
Q37707485 | Sex hormone drives blood stem cell reproduction. |
Q92971685 | Signaling pathways involved in chronic myeloid leukemia pathogenesis: The importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells |
Q36248867 | Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia |
Q35561510 | The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development |
Q38998213 | The Interaction Between Niche and Hematopoietic Stem Cells |
Q38254181 | The cancer stem cell hypothesis: a guide to potential molecular targets |
Q36547690 | The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML. |
Q38632898 | The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development |
Q26997109 | Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development |
Search more.